The preterm prediction study: Patterns of cervicovaginal fetal fibronectin as predictors of spontaneous preterm delivery


      OBJECTIVE: Our purpose was to determine how various temporal patterns of fetal fibronectin positivity from 24 to 30 weeks predict subsequent fetal fibronectin test results and spontaneous preterm delivery. STUDY DESIGN: A total of 2929 women had vaginal and cervical fetal fibronectin tests obtained at least once at 24, 26, 28, or 30 weeks, and 1870 women had tests performed at all four gestational ages. Fetal fibronectin values ≥50 ng/ml were considered positive. Various patterns of positive and negative tests were evaluated for prediction of (1) whether the next fetal fibronectin test would be positive or negative and (2) the percent of women with a spontaneous preterm delivery ≥4 weeks after the last fetal fibronectin test at <30, <32, <35, and <37 weeks' gestational age. RESULTS: Women with previous negative test results had only a 3% chance of a subsequent positive test result; however, if the last test result was positive, 29% of the next tests were positive. Of the 1870 women with tests at 24, 26, 28, and 30 weeks, 89% had all negative results, 8.4% had one positive result, 1.8% had two positive results, and 0.8% had three or four positive results. The higher the percent of positive tests at 24 to 26 weeks, at 28 to 30 weeks, or at 24 to 30 weeks, the greater the risk of subsequent spontaneous preterm birth. As an example, the risk of spontaneous preterm birth at <30 weeks for women with two negative fetal fibronectin test results at 24 and 26 weeks was 0.3% versus 16% for women with two positive results. CONCLUSION: The presence of a positive cervical or vaginal fetal fibronectin test result predicts subsequent positive fetal fibronectin positivity and subsequent spontaneous preterm birth. The greater the percent of positive results, the higher is the risk of spontaneous preterm birth. After a positive test result, two negative results are required before the risk of spontaneous preterm birth returns to baseline.(Am J Obstet Gynecol 1997;177:8-12.)


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Goldenberg RL
        • Mercer BM
        • Meis PJ
        • Copper RL
        • Das A
        • McNellis D.
        The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth.
        Obstet Gynecol. 1996; 87: 643-648
        • Lockwood CJ
        • Senyei AE
        • Dische MR
        • Casal D
        • Shah KD
        • Thung SN
        • et al.
        Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery.
        N Engl J Med. 1991; 325: 669-674
        • Lockwood CJ
        • Wein R
        • Lapinski R
        • Casal D
        • Berkowitz G
        • Alvarez M
        • et al.
        The presence of cervical and vaginal fetal fibronectin predicts preterm delivery in an inner-city obstetric population.
        Am J Obstet Gynecol. 1993; 169: 798-804
        • Nageotte MP
        • Casal D
        • Senyei AE.
        Fetal fibronectin in patients at increased risk for premature birth.
        Am J Obstet Gynecol. 1994; 170: 20-25
        • Iams JD
        • Casal D
        • McGregor JA
        • Goodwin TM
        • Kreaden US
        • Lowensohn R
        • et al.
        Fetal fibronectin improves the accuracy of diagnosis of preterm labor.
        Am J Obstet Gynecol. 1995; 173: 141-145
        • Hellemans P
        • Gerris J
        • Verdonk P.
        Fetal fibronectin detection for prediction of preterm birth in low risk women.
        Br J Obstet Gynaecol. 1995; 102: 207-212
        • Burrus DR
        • Ernest JM
        • Veille JC.
        Fetal fibronectin, interleukin-6, and C-reactive protein are useful in establishing prognostic subcategories of idiopathic preterm labor.
        Am J Obstet Gynecol. 1995; 173: 1258-1262
        • Morrison JC
        • Naef III, RW
        • Botti JJ
        • Katz M
        • Belluomini JM
        • McLaughlin BN.
        Prediction of spontaneous preterm birth by fetal fibronectin and uterine activity.
        Obstet Gynecol. 1996; 87: 649-655
        • Goldenberg RL
        • Thom E
        • Moawad AH
        • Johnson F
        • Roberts J
        • Caritis SN.
        The preterm prediction study: fetal fibronectin, bacterial vaginosis and peripartum infection.
        Obstet Gynecol. 1996; 87: 656-660
        • Cassell G
        • Hauth J
        • Andrews W
        • Cutter G
        • Goldenberg R.
        Chorioamnion colonization: correlation with gestational age in women delivered following spontaneous labor versus indicated delivery.
        Am J Obstet Gynecol. 1993; 168 ([abstract]): 425
        • Gibbs RS
        • Romero R
        • Hillier SL
        • Eschenbach DA
        • Sweet RL.
        A review of premature birth and subclinical infection.
        Am J Obstet Gynecol. 1992; 166: 1515-1528
        • Krohn MA
        • Hillier SL
        • Nugent RP
        • Cotch MF
        • Carey JC
        • Gibbs RS
        • et al.
        The genital flora of women with intraamniotic infection.
        J  Infect Dis. 1995; 171: 1475-1480
        • Watts DH
        • Krohn MA
        • Hillier SL
        • Eschenbach DA.
        The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor.
        Obstet Gynecol. 1992; 79: 351-357
        • Hiller SL
        • Krohn MA
        • Kiviat NB
        • Watts DH
        • Eschenbach DA.
        Microbiologic causes and neonatal outcomes associated with chorioamnion infection.
        Am J Obstet Gynecol. 1991; 165: 955-961